SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Babe Didrikson Zaharias — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMildred Ella Didrikson Zaharias
Date of birth1911-06-26
IdentifiersMRN HR-ML038-SYN-TD; SSN (made up) 000-38-4471
Document date1953-08-10
AuthorRosalind Vasquez-Thornbury, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit, on the day of cycle 7 of dostarlimab. [S]

History of Present Illness

Ms. Didrikson Zaharias, now 42, comes for her yearly preventive visit on the morning of her seventh dose of dostarlimab. Six weeks ago, at the restaging visit, the tumor had almost gone on MRI and endoscopy, and levothyroxine 75 micrograms was started for immune-related hypothyroidism. She takes it on waking, four hours apart from her iron, and the tiredness and cold hands have gone. Her bowel movements are normal, with no blood, urgency or pain. She is playing 18 holes most days and finished third in a regional event last week. She has had no diarrhea, rash, cough or breathlessness since the cold in June. Her PHQ-9 today is 2. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 42
Active conditionsMismatch repair-deficient low rectal cancer on dostarlimab with a near-complete response; immune-related hypothyroidism on levothyroxine; iron deficiency anemia, recovering
MedicinesDostarlimab every three weeks; levothyroxine 75 micrograms daily; ferrous sulfate 325 mg on alternate days; levonorgestrel intrauterine device
MoodPHQ-9 2

Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Vasquez-Thornbury. [S]

DomainFinding
Self-rated healthVery good
PsychosocialBusy with tournaments and the club; worried at times that the cancer will come back; sleeps well
TobaccoNever smoked
Alcohol and drugsA drink once or twice a month; no drugs
Physical activityGolf most days, walking the course; strength work three times a week
NutritionHas cut red meat to twice a week and eats more vegetables and whole grains
Sun exposureOutdoors most of the day; uses sunscreen inconsistently; wears a visor
Sexual and reproductive healthSex comfortable again since the bleeding stopped; levonorgestrel IUD in place; not planning a pregnancy
Safety at homeFeels safe; no one hurts, threatens or controls her; no firearm in the home
Road safetyWears a seat belt; drives long distances between tournaments and stops to rest
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, night sweats or weight loss; energy back to normal
EyesNegativeNo vision change; eye examination last year
Ears, nose, mouth, and throatNegativeNo mouth sores
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNormal bowel movements; no blood, urgency or pain
GenitourinaryNegativeLight periods with the IUD; no urinary symptoms
BreastNegativeNo lump or nipple discharge
MusculoskeletalNegativeNo joint pain or swelling
IntegumentaryNegativeNo rash or itching; no changing moles
NeurologicalNegativeNo headache or numbness
EndocrineNegativeCold intolerance gone; no thirst
PsychiatricNegativeMood good; PHQ-9 2; no thoughts of self-harm

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other morningOne tablet every other morningOral route1953-03-30activeS
Dostarlimab-gxly 50 mg/mL injection, 500 mg intravenously over 30 minutes every 3 weeks, for nine doses (six months)500 mg every 3 weeks for nine dosesIntravenous route1953-04-06 to 1953-09-21completedS
Levothyroxine 75 microgram oral tablet, one tablet by mouth each morning on an empty stomach, four hours apart from ironOne tablet each morningOral route1953-06-29activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1953-08-10Body height168cmS
1953-08-10Body weight63.6kgS
1953-08-10Body mass index (BMI) [Ratio]22.5kg/m2S
1953-08-10Systolic blood pressure112mm[Hg]S
1953-08-10Diastolic blood pressure68mm[Hg]S
1953-08-10Heart rate62/minS
1953-08-10Respiratory rate14/minS
1953-08-10Body temperature36.5CelS
1953-08-10Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1953-08-10Thyrotropin [Units/volume] in Serum or Plasma3.1m[IU]/L0.45-4.5 mIU/LNormalS
1953-08-10Thyroxine (T4) free [Mass/volume] in Serum or Plasma1.1ng/dL0.8-1.8 ng/dLNormalS
1953-08-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 1953-08-10; see the Vital Signs section. [S]

SystemFinding
ConstitutionalFit and well; weight 63.6 kg, BMI 22.5; blood pressure 112/68
Head, eyes, ears, nose, and throatNormal
NeckThyroid not enlarged or tender; no lymph nodes
BreastsExamined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation bilaterally
AbdomenSoft, non-tender; no liver enlargement or mass
SkinSun-damaged skin on the forearms, face and neck; several solar lentigines; no lesion suspicious for melanoma or other skin cancer
MusculoskeletalFull range of movement of the spine, shoulders and hips
PsychiatricCheerful, quick and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Bright red blood with bowel movements for about three months, with narrower stools, urgency, a feeling of incomplete emptying, and a firm, ulcerated mass felt on the back wall of the lower rectum at about 5 cm from the anal verge: a rectal cancer must be confirmed or excluded. Colonoscopy with biopsy booked this weekresolvedconfirmed K62.5S — Synthetic presenting problem anchored to the documented fatigue before her cancer diagnosis. Superseded by the diagnosis at the second visit.
Iron deficiency anemia from chronic rectal blood loss: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, with tirednessactiveconfirmed D50.0S — Synthetic finding anchored to the documented fatigue at the end of the 1952 season.
Adenocarcinoma of the low rectum, mismatch repair deficient (loss of MSH2 and MSH6; microsatellite instability high), cT3bN1M0 (stage IIIB) on pelvic MRI, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, mesorectal fascia clear, no extramural venous invasion; CEA 5.8 ng/mL; synthetic modern detail linked to her documented cancer, whose site the sources do not record exactlyactiveconfirmed C20S — Synthetic histology, site, stage, mismatch repair status and course; the sources say she had cancer treated with a colostomy and call it colon cancer (R on the site). See sources.md.
Acute viral upper respiratory infection with cough and sore throat, a week before cycle 4 of dostarlimab; oxygen saturation and chest X-ray normal, so immune-related pneumonitis is unlikely; rapid influenza and COVID-19 tests negative; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness; not a historical claim.
Immune-related primary hypothyroidism from dostarlimab, grade 2: tiredness and cold hands, TSH 12.6 mIU/L and free T4 0.6 ng/dL after four doses, following a mild TSH rise four weeks earlier; dostarlimab continuedactiveconfirmed E03.2S — Synthetic common immune-related adverse event of PD-1 blockade.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today112/68 mmHg
Depression screeningCompleted todayPHQ-9 score 2; item 9 scored 0
Unhealthy alcohol use screeningCompleted todayOne or two drinks a month
Tobacco useCompleted todayNever smoked
Intimate partner violence screeningCompleted todayNegative; she feels safe
Breast cancer screeningOrderedMammogram every two years from 40; first screening mammogram ordered
Cervical cancer screeningUp to dateHPV and cytology co-test two years ago, normal; next in three years
Colorectal cancer screeningNot indicatedScreening does not apply: she is under cancer surveillance with MRI, endoscopy and colonoscopy
HIV, hepatitis B and hepatitis C screeningUp to dateAll negative before treatment; hepatitis B surface antibody negative
Prediabetes and diabetes screeningNot indicatedBMI 22.5 with no other risk factor; fasting glucose normal before each cycle
Lipid screeningUp to dateLipid panel three years ago normal
Skin cancer prevention counselingCompleted todaySun protection for an outdoor athlete; skin examined, no suspicious lesion
Hepatitis B vaccineCompleted todayDose 1 of the two-dose adjuvanted series; dose 2 in one month or later
Influenza vaccineDueWhen this season's vaccine is available
COVID-19 vaccineDueThis season's vaccine in the autumn
Tetanus, diphtheria, and pertussisUp to dateTdap five years ago
Recombinant zoster vaccineNot indicatedRecommended from 50, or from 19 for immunosuppression; PD-1 blockade alone is not immunosuppressive treatment
Contraception counselingCompleted todayLevonorgestrel IUD continued during treatment and for at least four months after the last dose
Dental and vision examinationDueDental cleaning due; eye examination next year

Immunizations given today: Hepatitis B vaccine (adjuvanted, two-dose series), dose 1 [S]

Guideline basis: Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: Cycle 7 today; cycles 8 and 9 as booked; hepatitis B dose 2 at cycle 9; mammogram; final restaging after cycle 9. Next preventive visit in one year. Next scheduled visit 1953-10-05: after nine doses: final restaging, clinical complete response, and the watch-and-wait surveillance plan. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care proxy form. She said that she wants every treatment with a real chance of controlling the cancer, including surgery and a colostomy if the tumor ever regrows, and wants to be told the facts at once and in plain words. If she were ever too ill to decide and unlikely to recover, she would want care aimed at comfort, with her pain fully treated. To be revisited at each change in her health and at least yearly. [S]